AngioDynamics, Inc. (ANGO) Free cash flow 2017–2026
AngioDynamics, Inc. (ANGO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$508,000FY2026 · since FY2017: $52.7M → $508,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $508,000 | +103.5% |
| FY2025 | -$14.6M | +52.4% |
| FY2024 | -$30.7M | -721.5% |
| FY2023 | -$3.7M | +67.5% |
| FY2022 | -$11.5M | -160.8% |
| FY2021 | $18.9M | +186.8% |
| FY2020 | -$21.8M | -163.5% |
| FY2019 | $34.3M | -11.8% |
| FY2018 | $38.9M | -26.3% |
| FY2017 | $52.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice